Sequent Scientific Ltd.
SEQUENT Share PricePharmaceuticals & Drugs
₹185.67
1.9 (1%)
As on September 8, 2025
Exchange Scrips: BSE512529NSESEQUENTISININE807F01027
Market Cap ₹ 4,626 Cr
P/E Ratio 294.25
Dividend Yield N/A
Performance
Market performance
Open185.6
High188.29
Volumes6,32,913
Prev185.67
Low183
As on2025-09-08
Historical performance
1 Year High240.7
3 Year High240.7
5 Year High336.5
1 Year Low117.35
3 Year Low61.8
5 Year Low61.8
Fundamentals
Company Valuation
Market Cap (₹Cr)
4,626
Face Value (₹)
2
P/E Ratio
294.25
Dividend Yield
N/A
Investment Returns
1 Year
6.9%
3 Years
57.4%
5 Years
32.2%
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 178.96 | Bullish |
| 10-DMA | 175.35 | Bullish |
| 20-DMA | 175.03 | Bullish |
| 50-DMA | 179.67 | Bullish |
| 100-DMA | 177.37 | Bullish |
| 200-DMA | 171.89 | Bullish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 1 | 1 | 1 | 1 | 1 |
| Foreign Investors | 1 | 1 | 1 | 1 | --- |
| Domestic Investors | --- | --- | --- | --- | 1 |
| Public Investors | 147319 | 158151 | 162573 | 154602 | 163692 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 294.25.
- 3Y Stock Price CAGR of the stock is 17.0.
- The stock has a beta of 1.5.
- In the last financial year, the company had an EBITDA of ₹396 Million.
- The company generated revenue of ₹1783 Million in the previous financial year.
Sequent Scientific Ltd.
185.671.9 (1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1054883.2
No. of Shares: 5681 (Approx)
Performance:5.5%
P/L: ₹54883.2
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent